ScienceDex / Researcher record
Srinivas Raghavan Viswanathan
- Dana-Farber Cancer Institute (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- R01 Holder
- Early Career
- Diverse Portfolio
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,470,636 | 3 | #8,911 |
| 2025 | $2,985,210 | 4 | #3,433 |
| 2026 | $1,947,892 | 4 | #10,741 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20243 records
- FY20254 records
- FY2026 · selected4 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12344771Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award records by amount
NIH award records listing Srinivas Raghavan Viswanathan as a PI. Multi-PI records show the full award amount for context.
- 1R01CA302918-01A1R01Contact PIFrom biology to therapy: mechanism-informed targeting in translocation renal cell carcinoma$737.1Kaward amount
- 5U01CA269505-04U01Contact PIRegulation of androgen receptor signaling in prostate cancer by protein arginine methylation$507.1Kaward amount
- 5R01CA279044-04R01Contact PIMolecular mechanisms and therapeutic targeting of activated NRF2 signaling in MiT/TFE translocation renal cell carcinoma$495.7Kaward amount
- 5R21CA296230-02R21Contact PITargeting the CDK4/6 pathway in MiT/TFE-translocation renal cell carcinoma$208Kaward amount
Award organization
Organizations that administered FY2026 awards listing Srinivas Raghavan Viswanathan as a PI.
FY2026 award administered by Dana-Farber Cancer Institute (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDana-Farber Cancer Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #8911
- 2025$2M Cumulative Funding
- 2025Entered Top 25% NationallyRanked #3433
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Srinivas Raghavan Viswanathan.